Offices – United Kingdom
Explore all Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights – United Kingdom
Explore all insights
Expertise
Insights
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights
About CMS
Responsible business highlights
Responsible business highlights

Learn more

Select your region

Lauren Gregory
Of Counsel

Lauren Gregory

Languages
  • English
Social media

Lauren is a European and UK Patent Attorney who specialises in the fields of molecular biology, immunology and biotechnology. Her practice focuses on patent prosecution, opposition and appeal work before the European Patent Office, including multi-party oppositions. Lauren is also experienced in the management of large European patent portfolios and associated strategic advice.

Lauren has particular expertise and interest in the areas of personalised medicine, peptide-based technology, vaccines, antisense oligonucleotides and gene therapy, antibody and antibody-conjugate technology, PCR technology, biomarkers, transgenic plant biotechnology, recombinant gene expression and stem cells.

Lauren studied natural sciences, specialising in genetics, at the University of Cambridge, and has a PhD in developmental neurobiology from University College London.

Relevant experience

  • Successful defence before the EPO Opposition Division of a CuRNA, Inc patent relating to therapeutic antisense oligonucleotides, resulting in maintenance of the patent as granted.
  • Successful defence before the EPO Opposition Division of a University of Iowa Research Foundation patent relating to therapeutic complement factor H polypeptides, resulting in rejection of the opposition and maintenance of the patent as granted.
  • Experience in multiple oppositions, both offensive and defensive, including defence of large multi-party oppositions.
  • Experience in devising and advising on the prosecution strategy of large and expanding patent portfolios, as well as coordinating the prosecution in multiple countries.
  • Assisting in achieving allowance at the EPO of AbbVie’s patent claims to the dual variable domain immunoglobulin format.
  • Assisting in achieving grant at the EPO of MedImmune’s (Astra Zeneca) anti-PD1 antibody patent.

Memberships & Roles

Member of CIPA and EPI

Education

2015 - Certificate in Basic Litigation Skills

2015 – EPA (European Patent Attorney)

2014 – CPA (Chartered Patent Attorney) 

2011 – PhD (Developmental Neurobiology), UCL

2007 – BA (Natural Sciences - Genetics), University of Cambridge